Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients.
CONCLUSION: US imaging is insufficient to predict pCR with adequate accuracy. Receptor subtypes, however, affect diagnostic precision of US and pathologic outcome.
PMID: 29518677 [PubMed - as supplied by publisher]
Source: Breast - Category: Cancer & Oncology Authors: Baumgartner A, Tausch C, Hosch S, Papassotiropoulos B, Varga Z, Rageth C, Baege A Tags: Breast Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Ultrasound